iSpecimen (ISPC) Gains from Investment Securities (2020 - 2026)
iSpecimen (ISPC) recorded quarterly Gains from Investment Securities of $139.0 in Q1 2026, down 99.81% quarter-over-quarter from $73180.0 in Q4 2025, and down 99.79% on a YoY basis from $67224.0 in Q1 2025.
iSpecimen (ISPC) Gains from Investment Securities (2020 - 2026) Analysis & Trends
iSpecimen's Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $139.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities fell 99.79% year-over-year to $139.0; the TTM figure through Mar 2026 stood at $139.0 (down 99.79% YoY), while the FY2025 annual figure was $73180.0, down 88.21% from the prior year.
- Gains from Investment Securities was $139.0 for Q1 2026 at iSpecimen, down from $73180.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $350062.0 in Q1 2024 to a low of $139.0 in Q1 2026.
- Historically, Gains from Investment Securities has averaged $94985.8 across 5 years, with a median of $67224.0 in 2025.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities surged 9815.99% in 2025, then tumbled 99.79% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at $164131.0 in 2022, then plunged by 94.45% to $9115.0 in 2023, then sank by 91.9% to $738.0 in 2024, then soared by 9815.99% to $73180.0 in 2025, then plunged by 99.81% to $139.0 in 2026.
- The last three Gains from Investment Securities figures came in at $139.0 (Q1 2026), $73180.0 (Q4 2025), and $73084.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | iSpecimen | 1.02 Mn | -1.79 Mn | -1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 139.00 |
| Mar 31, 2026 | 139.00 |
| Dec 31, 2025 | 73,180.00 |
| Dec 31, 2025 | 73,180.00 |
| Sep 30, 2025 | 73,084.00 |
| Sep 30, 2025 | 73,084.00 |
| Jun 30, 2025 | 3,905.00 |
| Jun 30, 2025 | 3,905.00 |
| Mar 31, 2025 | 67,224.00 |
| Mar 31, 2025 | 67,224.00 |
| Dec 31, 2024 | 738.00 |
| Dec 31, 2024 | 738.00 |
| Sep 30, 2024 | 5,521.00 |
| Sep 30, 2024 | 5,521.00 |
| Jun 30, 2024 | 95,340.00 |
| Jun 30, 2024 | 95,340.00 |
| Mar 31, 2024 | 350,062.00 |
| Mar 31, 2024 | 350,062.00 |
| Sep 30, 2023 | 9,115.00 |
| Sep 30, 2023 | 9,115.00 |